JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, V. G.
Right arrow Articles by Burch, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, V. G.
Right arrow Articles by Burch, T. M.
Related Collections
Right arrow Blood
Right arrow Technology

Anesth Analg 2004;99:120-123
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000123012.24871.62

TECHNOLOGY, COMPUTING, AND SIMULATION

The Impact of Factor XIII on Coagulation Kinetics and Clot Strength Determined by Thrombelastography

Vance G. Nielsen, MD, William Q. Gurley, Jr, MD, and Thomas M. Burch, MD

Department of Anesthesiology, The University of Alabama at Birmingham

Address correspondence and reprint requests to Vance G. Nielsen, MD, Department of Anesthesiology, The University of Alabama at Birmingham, 619 S. 19th St., Birmingham, AL 35249-6810. Address e-mail to vance.nielsen{at}ccc.uab.edu

Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0%, 1%, 6.25%, 12.5%, 25%, 50%, and 100% normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1% tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), {alpha} (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R2 = 0.77; P < 0.001). FXIII activity significantly increased {alpha}, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R2 = 0.89; P < 0.001). We concluded that FXIII significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.

IMPLICATIONS: Changes in fibrinogen concentration have been implicated as the primary determinant of protein-mediated clot strength via thrombelastography. We determined that factor XIII (FXIII) activity significantly enhanced clot strength and speed of clot initiation and formation. Transfusion decision making with thrombelastography must account for the contribution of both fibrinogen and FXIII.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
T. Haas, D. Fries, C. Velik-Salchner, C. Reif, A. Klingler, and P. Innerhofer
The In Vitro Effects of Fibrinogen Concentrate, Factor XIII and Fresh Frozen Plasma on Impaired Clot Formation After 60% Dilution
Anesth. Analg., May 1, 2008; 106(5): 1360 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, E. Oswald, C. Bach, M. Schnapka-Koepf, and P. Innerhofer
Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration
Anesth. Analg., October 1, 2007; 105(4): 905 - 917.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
S. T. Morozowich, B. S. Donahue, and I. J. Welsby
Genetics of coagulation: considerations for cardiac surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 297 - 313.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. E. Adams and J. A. Huntington
Thrombin-Cofactor Interactions: Structural Insights Into Regulatory Mechanisms
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1738 - 1745.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2004 by the International Anesthesia Research Society.